Page last updated: 2024-08-23

raloxifene hydrochloride and Recrudescence

raloxifene hydrochloride has been researched along with Recrudescence in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Azami, N; Chen, PJ; Dutra, EH; Kalajzic, Z; Mehta, S; Nanda, R; Yadav, S1
Bauer, DC; Clarke, BL; Drake, MT; Tsourdi, E; Yu, EW1
Chiodini, A; Odorizzi, MP; Pompei, F; Somigliana, E; ViganĂ², P1
Adachi, JD; Crans, GG; Delmas, PD; Genant, HK; Siris, E; Stock, JL; Wong, M1
Deng, W; He, W1
Leondires, M; Nieman, LK; Parker, JD; Premkumar, A; Sinaii, N; Stratton, P1
Koziol, D; Nieman, LK; Segars, J; Sinaii, N; Stratton, P; Wesley, R; Winkel, C; Zimmer, C1
Adachi, JD; Harper, KD; Maricic, M; Sarkar, S; Wong, M; Wu, W1

Reviews

1 review(s) available for raloxifene hydrochloride and Recrudescence

ArticleYear
[The therapy of endometriosis. New prospects].
    Minerva ginecologica, 2003, Volume: 55, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Clinical Trials as Topic; Drug Evaluation, Preclinical; Endometriosis; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Hypothalamo-Hypophyseal System; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Papio; Pregnancy; Pregnancy Rate; Raloxifene Hydrochloride; Rats; Recurrence; Selective Estrogen Receptor Modulators; Tissue Adhesions

2003

Trials

4 trial(s) available for raloxifene hydrochloride and Recrudescence

ArticleYear
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
    Bone, 2003, Volume: 33, Issue:4

    Topics: Aged; Bone Density; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Recurrence; Risk Factors; Spinal Fractures

2003
Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis.
    Fertility and sterility, 2006, Volume: 86, Issue:3

    Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Laparoscopy; Pelvic Pain; Raloxifene Hydrochloride; Recurrence; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Failure; Treatment Outcome

2006
Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial.
    Obstetrics and gynecology, 2008, Volume: 111, Issue:1

    Topics: Adult; Chronic Disease; Endometriosis; Female; Humans; Laparoscopy; Pelvic Pain; Quality of Life; Raloxifene Hydrochloride; Recurrence; Selective Estrogen Receptor Modulators; Treatment Outcome

2008
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis.
    Archives of internal medicine, 2002, May-27, Volume: 162, Issue:10

    Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Incidence; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Recurrence; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Time Factors

2002

Other Studies

3 other study(ies) available for raloxifene hydrochloride and Recrudescence

ArticleYear
Raloxifene administration enhances retention in an orthodontic relapse model.
    European journal of orthodontics, 2020, 09-11, Volume: 42, Issue:4

    Topics: Animals; Bone Remodeling; Male; Molar; Osteoclasts; Raloxifene Hydrochloride; Rats; Rats, Wistar; Recurrence; Tooth Movement Techniques

2020
Osteoporosis Management in the Era of COVID-19.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020, Volume: 35, Issue:6

    Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Density Conservation Agents; Continuity of Patient Care; Coronavirus Infections; COVID-19; Denosumab; Disease Management; Drug Administration Schedule; Estrogen Replacement Therapy; Fractures, Spontaneous; Home Care Services; Humans; Immunosuppression Therapy; Osteoporosis; Pandemics; Pneumonia, Viral; Raloxifene Hydrochloride; Recurrence; Telemedicine; Thrombophilia; Unnecessary Procedures

2020
Identifying methodologies in the assessment of treatment effects on the repeated occurrences of hot flashes in postmenopausal women.
    Clinical trials (London, England), 2005, Volume: 2, Issue:6

    Topics: Analysis of Variance; Clinical Trials as Topic; Computer Simulation; Female; Hot Flashes; Humans; Logistic Models; Markov Chains; Models, Statistical; Raloxifene Hydrochloride; Recurrence; Research Design; Selective Estrogen Receptor Modulators; Severity of Illness Index; Time Factors; Treatment Outcome

2005